BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 37539726)

  • 1. METTL14‑mediated RNA methylation in digestive system tumors.
    Hu J; Lin H; Wang C; Su Q; Cao B
    Int J Mol Med; 2023 Sep; 52(3):. PubMed ID: 37539726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer.
    Shi B; Liu WW; Yang K; Jiang GM; Wang H
    Mol Cancer; 2022 Aug; 21(1):163. PubMed ID: 35974338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging function of main RNA methylation modifications in the immune microenvironment of digestive system tumors.
    Zeng Y; Yu T; Lou Z; Chen L; Pan L; Ruan B
    Pathol Res Pract; 2024 Apr; 256():155268. PubMed ID: 38547773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of m6A RNA methylation in cardiovascular disease (Review).
    Qin Y; Li L; Luo E; Hou J; Yan G; Wang D; Qiao Y; Tang C
    Int J Mol Med; 2020 Dec; 46(6):1958-1972. PubMed ID: 33125109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
    Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
    Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of N6-methyladenosine modification on metabolic reprogramming in digestive tract tumors.
    Yu L; Gao Y; Bao Q; Xu M; Lu J; Du W
    Heliyon; 2024 Jan; 10(2):e24414. PubMed ID: 38293446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting key RNA methylation enzymes to improve the outcome of colorectal cancer chemotherapy (Review).
    Shao C; Han Y; Huang Y; Zhang Z; Gong T; Zhang Y; Tian X; Fang M; Han X; Li M
    Int J Oncol; 2024 Feb; 64(2):. PubMed ID: 38131226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
    Xie Q; Li Z; Luo X; Wang D; Zhou Y; Zhao J; Gao S; Yang Y; Fu W; Kong L; Sun T
    J Transl Med; 2022 Jan; 20(1):51. PubMed ID: 35093098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA m6A methylation and regulatory proteins in pulmonary arterial hypertension.
    Wang Z; Zhang YX; Shi JZ; Yan Y; Zhao LL; Kou JJ; He YY; Xie XM; Zhang SJ; Pang XB
    Hypertens Res; 2024 May; 47(5):1273-1287. PubMed ID: 38438725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RNA m6A writer METTL14 in cancers: Roles, structures, and applications.
    Zhou H; Yin K; Zhang Y; Tian J; Wang S
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188609. PubMed ID: 34375716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of METTL3 and METTL14 in hepatocellular carcinoma.
    Liu X; Qin J; Gao T; Li C; Chen X; Zeng K; Xu M; He B; Pan B; Xu X; Pan Y; Sun H; Xu T; Wang S
    Aging (Albany NY); 2020 Nov; 12(21):21638-21659. PubMed ID: 33159022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into roles of METTL14 in tumors.
    Liu X; Du Y; Huang Z; Qin H; Chen J; Zhao Y
    Cell Prolif; 2022 Jan; 55(1):e13168. PubMed ID: 34904301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
    J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of RNA m6A methylation in lipid metabolism.
    Wang Y; Wang Y; Gu J; Su T; Gu X; Feng Y
    Front Endocrinol (Lausanne); 2022; 13():866116. PubMed ID: 36157445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of m6A modification in immune microenvironment of digestive system tumors.
    Li C; Zhu M; Wang J; Wu H; Liu Y; Huang D
    Biomed Pharmacother; 2023 Aug; 164():114953. PubMed ID: 37269812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation.
    Li Q; Li X; Tang H; Jiang B; Dou Y; Gorospe M; Wang W
    J Cell Biochem; 2017 Sep; 118(9):2587-2598. PubMed ID: 28247949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies.
    Cai X; Liang C; Zhang M; Xu Y; Weng Y; Li X; Yu W
    Cancer Lett; 2022 Sep; 544():215815. PubMed ID: 35798087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.